Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors

The calcitonin receptor is a member of the class B family of G protein-coupled receptors, closely related to secretin and parathyroid hormone receptors. Although mechanisms of ligand binding have been directly explored for those receptors, current knowledge of the molecular basis of calcitonin binding to its receptor is based only on receptor mutagenesis. In this work we have utilized the more direct approach of photoaffinity labeling to explore spatial approximations between distinct residues within calcitonin and its receptor. For this we have developed two human calcitonin analogues incorporating a photolabile p-benzoyl-l-phenylalanine residue in the mid-region and carboxyl-terminal half of the peptide in positions 16 and 26, respectively. Both probes specifically bound to the human calcitonin receptor with high affinity and were potent stimulants of cAMP accumulation in calcitonin receptor-bearing human embryonic kidney 293 cells. They covalently labeled the calcitonin receptor in a saturable and specific manner. Further purification, deglycosylation, specific chemical and enzymatic cleavage, and sequencing of labeled wild type and mutant calcitonin receptors identified the sites of labeling for the position 16 and 26 probes as receptor residues Phe137 and Thr30, respectively. Both were within the extracellular amino terminus of the calcitonin receptor, with the former adjacent to the first transmembrane segment and the latter within the distal amino-terminal tail of the receptor. These data are consistent with affinity labeling of other members of the class B G protein-coupled receptors using analogous probes and may suggest a common ligand binding mechanism for this family.

[1]  T. Lybrand,et al.  Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor , 2003, Journal of Biological Chemistry.

[2]  A. Couvineau,et al.  Photoaffinity Labeling Demonstrates Physical Contact between Vasoactive Intestinal Peptide and the N-terminal Ectodomain of the Human VPAC1 Receptor* , 2003, Journal of Biological Chemistry.

[3]  T. Lybrand,et al.  Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. , 2003, Molecular pharmacology.

[4]  L. Miller,et al.  Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10 , 2002, Regulatory Peptides.

[5]  T. Lybrand,et al.  Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. , 2002, Molecular endocrinology.

[6]  R. Rudolph,et al.  In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor. , 2002, Biophysical chemistry.

[7]  L. Miller,et al.  Molecular pharmacology of the secretin receptor. , 2002, Receptors & channels.

[8]  P. Sexton,et al.  Molecular pharmacology of the calcitonin receptor. , 2002, Receptors & channels.

[9]  H. Jüppner,et al.  Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis* , 2001, The Journal of Biological Chemistry.

[10]  L. Miller,et al.  Identification of Peptide Ligand-binding Domains within the Human Motilin Receptor Using Photoaffinity Labeling* , 2001, The Journal of Biological Chemistry.

[11]  W. Fischer,et al.  Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor* , 2001, The Journal of Biological Chemistry.

[12]  H. Jüppner,et al.  Multiple Sites of Contact between the Carboxyl-terminal Binding Domain of PTHrP-(1–36) Analogs and the Amino-terminal Extracellular Domain of the PTH/PTHrP Receptor Identified by Photoaffinity Cross-linking* , 2001, Journal of Biological Chemistry.

[13]  T. Lybrand,et al.  Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe* , 2001, The Journal of Biological Chemistry.

[14]  M. Pondel,et al.  Calcitonin and calcitonin receptors: bone and beyond , 2000, International journal of experimental pathology.

[15]  Y. Asmann,et al.  Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. , 2000, Molecular pharmacology.

[16]  Y. Asmann,et al.  Identification of Two Pairs of Spatially Approximated Residues within the Carboxyl Terminus of Secretin and Its Receptor* , 2000, The Journal of Biological Chemistry.

[17]  R. Rudolph,et al.  The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. , 2000, Biochemistry.

[18]  M. Chorev,et al.  Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. , 2000, Biochemistry.

[19]  G. Bitan,et al.  Photoaffinity Cross-linking Identifies Differences in the Interactions of an Agonist and an Antagonist with the Parathyroid Hormone/Parathyroid Hormone-related Protein Receptor* , 2000, The Journal of Biological Chemistry.

[20]  L. Miller,et al.  Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor* , 1999, The Journal of Biological Chemistry.

[21]  L. Miller,et al.  Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling* , 1999, The Journal of Biological Chemistry.

[22]  L. Miller,et al.  Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. , 1998, The Journal of pharmacology and experimental therapeutics.

[23]  H. Jüppner,et al.  Evidence for a Ligand Interaction Site at the Amino-Terminus of the Parathyroid Hormone (PTH)/PTH-related Protein Receptor from Cross-linking and Mutational Studies* , 1998, The Journal of Biological Chemistry.

[24]  T. Lybrand,et al.  Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its Receptor* , 1998, The Journal of Biological Chemistry.

[25]  L. Suva,et al.  Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[26]  T. Lybrand,et al.  Direct Identification of a Distinct Site of Interaction between the Carboxyl-terminal Residue of Cholecystokinin and the Type A Cholecystokinin Receptor Using Photoaffinity Labeling* , 1997, The Journal of Biological Chemistry.

[27]  L. Suva,et al.  Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Sexton,et al.  Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system. , 1997, Molecular pharmacology.

[29]  J. Vilardaga,et al.  The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors , 1996, Peptides.

[30]  S. Goldring,et al.  Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin , 1996, The Journal of Biological Chemistry.

[31]  J. Bockaert,et al.  Alternative Splicing in the N-terminal Extracellular Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor Modulates Receptor Selectivity and Relative Potencies of PACAP-27 and PACAP-38 in Phospholipase C Activation* , 1996, The Journal of Biological Chemistry.

[32]  L. Miller,et al.  Relationship Between Native and Recombinant Cholecystokinin Receptors: Role of Differential Glycosylation , 1996, Pancreas.

[33]  J. Vilardaga,et al.  Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. , 1996, European journal of biochemistry.

[34]  L. Miller,et al.  Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.

[35]  Y. Cao,et al.  The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. , 1995, Biochemical and biophysical research communications.

[36]  J. Vilardaga,et al.  Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. , 1995, Biochemical and biophysical research communications.

[37]  L. Miller,et al.  Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*) , 1995, The Journal of Biological Chemistry.

[38]  T. Serwold,et al.  Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. , 1995, Biochemistry.

[39]  F. Cardinaux,et al.  N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivo. , 1992, Biochemical and biophysical research communications.

[40]  L. Miller,et al.  Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. , 2009, International journal of peptide and protein research.

[41]  T. Martin,et al.  Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications. , 1988, Endocrinology.

[42]  L. Miller,et al.  Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. , 1987, The Journal of biological chemistry.

[43]  T. Martin,et al.  Photoaffinity labeling of the calcitonin receptor. , 1987, Pharmacology & therapeutics.

[44]  T. Martin,et al.  Identification of the calcitonin receptor by chemical cross‐linking and photoaffinity labeling in human cancer cell lines , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  G. Milhaud,et al.  Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques. , 1986, European journal of biochemistry.

[46]  E. Kaiser,et al.  Amphiphilic secondary structure: design of peptide hormones. , 1984, Science.

[47]  T. Martin,et al.  Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. , 1982, The Journal of biological chemistry.

[48]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[49]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[50]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.